Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic comparison of carbetocin versus oxytocin during elective cesarean delivery in women with preeclampsia under spinal anesthesia
PACTR201909623653208Phase 3Recruiting
- Sponsor
- Beni-Suef University Hospital
- Start
- Sep 2019
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of carbetocin and oxytocin in preeclampsia (2 arms), sponsored by Beni-Suef University Hospital. Primary endpoint: Hemodynamic effect. Started Sep 2019; status: recruiting.
02
Drugs
carbetocinoxytocin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on PACTR201909623653208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201909623653208.